Literature DB >> 6794587

The relationship between peak velocity of saccadic eye movements and serum benzodiazepine concentration.

P R Bittencourt, P Wade, A T Smith, A Richens.   

Abstract

1 Six healthy male volunteers received single oral doses of 10 mg diazepam, 20 mg temazepam, 15 mg flurazepam, 5 mg nitrazepam, 10 mg desmethyl-diazepam and placebo in a double-blind randomized fashion. 2 Peak velocity of saccadic eye movements, serum benzodiazepine concentration, and subjective ratings of wakefulness and co-ordination were measured at intervals up to 12 h after drug administration. 3 All active treatments produced a statistically significant decrease in peak saccadic velocity. The effect of temazepam and diazepam was generally more pronounced than that of flurazepam, nitrazepam and desmethyl-diazepam. 4 There were log-linear correlations between peak saccadic velocity and serum benzodiazepine concentration after ingestion of temazepam, diazepam and nitrazepam. 5 These results demonstrate a clear relationship between serum benzodiazepine concentration and its effect on a convenient measure of brainstem reticular formation function.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6794587      PMCID: PMC1401908          DOI: 10.1111/j.1365-2125.1981.tb01261.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  39 in total

1.  Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholic and malnourished patients.

Authors:  R D ADAMS; M VICTOR; E L MANCALL
Journal:  AMA Arch Neurol Psychiatry       Date:  1959-02

2.  Elimination of paradoxical sleep by lesions of the pontine gigantocellular tegmental field in the cat.

Authors:  B E Jones
Journal:  Neurosci Lett       Date:  1979-08       Impact factor: 3.046

Review 3.  Neurophysiology of the states of sleep.

Authors:  M Jouvet
Journal:  Physiol Rev       Date:  1967-04       Impact factor: 37.312

4.  Locus of central depressant action of diazepam.

Authors:  A C Przybyla; S C Wang
Journal:  J Pharmacol Exp Ther       Date:  1968-10       Impact factor: 4.030

5.  An efficient technique for determining characteristics of saccadic eye movements using a mini computer.

Authors:  A T Smith; P R Bittencourt; D S Lloyd; A Richens
Journal:  J Biomed Eng       Date:  1981-01

6.  Pharmacokinetics and metabolism of various benzodiazepines used as hypnotics.

Authors:  D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

Review 7.  Psychomotor function and psychoactive drugs.

Authors:  I Hindmarch
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

8.  Quantitative assessment of smooth-pursuit eye movements in healthy and epileptic subjects.

Authors:  P R Bittencourt; M A Gresty; A Richens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-12       Impact factor: 10.154

Review 9.  Clinical pharmacokinetics of chlordiazepoxide.

Authors:  D J Greenblatt; R I Shader; S M MacLeod; E M Sellers
Journal:  Clin Pharmacokinet       Date:  1978 Sep-Oct       Impact factor: 6.447

10.  Absence of REM and altered NREM sleep in patients with spinocerebellar degeneration and slow saccades.

Authors:  I Osorio; R B Daroff
Journal:  Ann Neurol       Date:  1980-03       Impact factor: 10.422

View more
  32 in total

1.  Proceedings of the British Pharmacological Society, British Pharmacology Section. 18-20 April 1990, Sheffield. Abstracts.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1990-08       Impact factor: 4.335

2.  The effect on motion sickness and oculomotor function of GR 38032F, a 5-HT3-receptor antagonist with anti-emetic properties.

Authors:  J R Stott; G R Barnes; R J Wright; C J Ruddock
Journal:  Br J Clin Pharmacol       Date:  1989-02       Impact factor: 4.335

3.  Objective and subjective assessments of the effects of flupentixol and benzodiazepines on human psychomotor performance.

Authors:  M J Mattila; M Mattila; K Aranko
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 4.  The use of kinetic-dynamic interactions in the evaluation of drugs.

Authors:  D B Campbell
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

5.  Pharmacodynamic response profiles of anxiolytic and sedative drugs.

Authors:  Xia Chen; Freerk Broeyer; Marieke de Kam; Joke Baas; Adam Cohen; Joop van Gerven
Journal:  Br J Clin Pharmacol       Date:  2017-03-17       Impact factor: 4.335

6.  Benzodiazepine pharmacodynamics: utility of eye movement measures.

Authors:  P P Roy-Byrne; D S Cowley; A Radant; D Hommer; D J Greenblatt
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  The effect of repeated doses of temazepam and nitrazepam on human psychomotor performance.

Authors:  G Tedeschi; A N Griffiths; A T Smith; A Richens
Journal:  Br J Clin Pharmacol       Date:  1985-10       Impact factor: 4.335

8.  Antihistamines and visual function: studies on dynamic acuity and the pupillary response to light.

Authors:  A N Nicholson; P A Smith; M B Spencer
Journal:  Br J Clin Pharmacol       Date:  1982-11       Impact factor: 4.335

9.  The contribution of oculography to early diagnosis of myasthenia gravis. A study of saccadic eye movements using the infrared reflection method in 22 cases.

Authors:  C E Sollberger; O Meienberg; H P Ludin
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1986

10.  The central nervous system effects of the partial GABA-Aα2,3 -selective receptor modulator AZD7325 in comparison with lorazepam in healthy males.

Authors:  Xia Chen; Gabriël Jacobs; Marieke de Kam; Judith Jaeger; Jaakko Lappalainen; Paul Maruff; Mark A Smith; Alan J Cross; Adam Cohen; Joop van Gerven
Journal:  Br J Clin Pharmacol       Date:  2014-12       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.